The role of orexin in stress

Progress in Biochemistry and Biophysics

Volumn 37, Issue 7, 2010, Pages 713-719

  Wei, Chu Guang ^a,b   Li, Yong Hui ^a   Han, Jin ^a,b   Wang, Hui Ying ^a,b   Sui, Nan ^a  

^a INSTITUTE OF PSYCHOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Drug addiction; Orexins (hypocretins); Relapse; Stress

Indexed keywords

EID: 77958504472     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2010.00047     Document Type: Review

References (44)

1. de Lecea L, Kilduff T S, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA, 1998, 95(1): 322-327
2. Nambu T, Sakurai T, Mizukami K, et al. Distribution of orexin neurons in the adult rat brain. Brain Res, 1999, 827(1-2): 243-260
3. Kalra S P, Dube M G, Pu S, et al. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev, 1999, 20(1): 68-100 (Pubitemid 29092036)
4. Harris G C, Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends Neurosci, 2006, 29(10): 571-577 (Pubitemid 44416459)
5. Han J, Li Y H, Bai Y J, et al. Prog Physiol Sci, 2007, 38 (4): 327-330
6. Furlong T M, Vianna D M, Liu L, et al. Hypocretin/orexin contributes to the expression of some but not all forms of stress and arousal. Eur J Neurosci, 2009, 30(8): 1603-1614
7. Mileykovskiy B Y, Kiyashchenko L I, Siegel J M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron, 2005, 46(5): 787-798
8. Chemelli R M, Willie J T, Sinton C M, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 1999, 98(4): 437-451
9. Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet, 2000, 355(9197): 39-40
10. Adamantidis A R, Zhang F, Aravanis A M, et al. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature, 2007, 450(7168): 420-424
11. Hara J, Beuckmann C T, Nambu T, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron, 2001, 30(2): 345-354
12. Thannickal T C, Moore R Y, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron, 2000, 27 (3): 469-474
13. Lazarus A. Treating neuroleptic malignant syndrome. Am J Psychiatry, 1984, 141(8): 1014-1015
14. Scammell T E, Saper C B. Orexin, drugs and motivated behaviors. Nat Neurosci, 2005, 8(10): 1286-1288
15. Samson W K, Bagley S L, Ferguson A V, et al. Hypocretin/orexin type 1 receptor in brain: role in cardiovascular control and the neuroendocrine response to immobilization stress. Am J Physiol Regul Integr Comp Physiol, 2007, 292(1): R382-387
16. Stricker-Krongrad A, Beck B. Modulation of hypothalamic hypocretin/orexin mRNA expression by glucocorticoids. Biochem Biophys Res Commun, 2002, 296(1): 129-133 (Pubitemid 35002066)
17. Sakamoto F, Yamada S, Ueta Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul Pept, 2004, 118(3): 183-191 (Pubitemid 38296732)
18. Baldo B A, Daniel R A, Berridge C W, et al. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol, 2003, 464(2): 220-237
19. Ida T, Nakahara K, Murakami T, et al. Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun, 2000, 270(1): 318-323
20. Winsky-Sommerer R, Boutrel B, de Lecea L. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. Mol Neurobiol, 2005, 32(3): 285-294 (Pubitemid 43024033)
21. Boutrel B, de Lecea L. Addiction and arousal: The hypocretin connection. Physiology & Behavior, 2008, 93(4-5): 947-951
22. Walling S G, Nutt D J, Lalies M D, et al. Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrus. J Neurosci, 2004, 24(34): 7421-7426
23. Chou T C, Lee C E, Lu J, et al. Orexin (hypocretin) neurons contain dynorphin. J Neurosci, 2001, 21(19): RC168
24. Okumura T, Takakusaki K. Role of orexin in central regulation of gastrointestinal functions. J Gastroenterol, 2008, 43(9): 652-660
25. Shirasaka T, Miyahara S, Kunitake T, et al. Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. Am J Physiol Regul IntegrComp Physiol, 2001, 281(4): R1114-1118
26. Zhang W, Sakurai T, Fukuda Y, et al. Orexin neuron-mediated skeletal muscle vasodilation and shift of baroreflex during defense response in mice. Am J Physiol Regul Integr Comp Physiol, 2006, 290(6): R1654-1663
27. Samson W K, Bagley S L, Ferguson A V, et al. Hypocretin/orexin type 1 receptor in brain: role in cardiovascular control and the neuroendocrine response to immobilization stress. Am J Physiol Regul Integr Comp Physiol, 2007, 292(1): R382-387
28. Kuwaki T, Li A, Nattie E. State-dependent central chemoreception: A role of orexin [J/OL]. Respir Physiol Neurobiol [2010-02-17] http://www.elsevier.com/ locate/resphysiol (doi: 10.1016/j .resp.2010. 02.006)
29. Kayaba Y, Nakamura A, Kasuya Y, et al. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol, 2003, 285(3): R581-593
30. Yoshimichi G, Yoshimatsu H, Masaki T, et al. Orexin-A regulates body temperature in coordination with arousal status. Exp Biol Med (Maywood), 2001, 226(5): 468-476
31. Shirasaka T, Nakazato M, Matsukura S, et al. Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol, 1999, 277(6 Part 2): R1780-1785
32. Matsuzaki I, Sakurai T, Kunii K, et al. Involvement of the serotonergic system in orexin-induced behavioral alterations in rats. Regul Pept, 2002, 104(1-3): 119-123
33. Suzuki M, Beuckmann C T, Shikata K, et al. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res, 2005, 1044(1): 116-121
34. Johnson P L, Truitt W, Fitz S D, et al. A key role for orexin in panic anxiety. Nat Med, 2009, 16(1): 111-115
35. Li Y, Li S, Sui N, et al. Orexin-A acts on the paraventricular nucleus of the midline thalamus to inhibit locomotor activity in rats. Pharmacol Biochem Behav, 2009, 93(4): 506-514
36. Li Y, Li S, Wei C, et al. Changes in emotional behavior produced by orexin microinjections in the paraventricular nucleus of the thalamus. Pharmacol Biochem Behav, 2010, 95(1): 121-128
37. Meaney M J, Bhatnagar S, Larocque S, et al. Individual differences in the hypothalamic-piruitary-adrenal stress response and the hypothalamic CRF system. Ann N Y Acad Sci, 1993, 697: 70-85
38. DiLeone R J, Georgescu D, Nestler E J. Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sci, 2003, 73(6): 759-768 (Pubitemid 36703270)
39. Harris G C, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature, 2005, 437(7058): 556-559 (Pubitemid 41613553)
40. Leshner A I. Addiction is a brain disease, and it matters. Science, 1997, 278(5335): 45-47
41. Shalev U, Grimm J W, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev, 2002, 54(1): 1-42 (Pubitemid 34208828)
42. Boutrel B, Kenny P J, Specio S E, et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA, 2005, 102(52): 19168-19173
43. Wang B, You Z B, Wise R A. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol Psychiatry, 2009, 65(10): 857-862
44. Li S, Kirouac G J. Projections from the paraventricular nucleus of the thalamus to the forebrain, with special emphasis on the extended amygdala. J Comp Neurol, 2008, 506(2): 263-287